Skip to main content
Digital Recording

Psychedelics & Racial Justice

Average Rating:
Monnica T. Williams, PhD, ABPP
1 Hour 05 Minutes
Audio and Video
Jul 28, 2022
Product Code:
Media Type:
Digital Recording
Never expires.


Psychedelics have been studied for the treatment of PTSD, depression, end-of-life anxiety, OCD, addictions, and a number of other mental health conditions. However, research studies of psychedelic psychotherapies have largely excluded people of colour, leaving important questions unaddressed for these populations.   

Dr. Williams will review relevant research, documenting exclusion based on the international literature. She will discuss ethnic minority mental health and how psychedelic therapies may help or hinder healing for people of colour.  Also discussed are next steps in ensuring that access to culturally-informed care is prioritized as several psychedelics move into late phase trials and expanded access, including the importance of culturally-informed approaches and training focused on therapy providers of colour. 


Planning Committee Disclosure - No relevant relationships All members of the PESI, Inc. planning committee have provided disclosures of financial relationships with ineligible organizations and any relevant non-financial relationships prior to planning content for this activity. None of the committee members had relevant financial relationships with ineligible companies or other potentially biasing relationships to disclose to learners. For speaker disclosures, please see the faculty biography.


This online program is worth 1.25 hours CPD.



Monnica T. Williams, PhD, ABPP's Profile

Monnica T. Williams, PhD, ABPP Related seminars and products

Dr. Monnica T. Williams is a board-certified licensed clinical psychologist and Associate Professor at the University of Ottawa, in the School of Psychology, where she is the Canada Research Chair in Mental Health Disparities. She is also the Clinical Director of the Behavioral Wellness Clinic in Connecticut, where she provides supervision and training to clinicians for empirically supported treatments. Prior to her move to Canada, Dr. Williams was on the faculty of the University of Pennsylvania Medical School (2007-2011), the University of Louisville in Psychological and Brain Sciences (2011-2016), where she served as the Director of the Center for Mental Health Disparities, and the University of Connecticut (2016-2019) where she had appointments in both Psychological Science and Psychiatry. Dr. Williams’ research focuses on BIPOC mental health, culture, and psychopathology, and she has published over 150 scientific articles on these topics. Current projects include the assessment of race-based trauma, barriers to treatment in OCD, improving cultural competence in the delivery of mental health care services, and interventions to reduce racism. This includes her work as a PI in a multisite study of MDMA-assisted psychotherapy for PTSD for people of color. She also gives diversity trainings nationally for clinical psychology programs, scientific conferences, and community organizations. She has served as the African American SIG leader for Association of Behavioral and Cognitive Therapies (ABCT), and currently is Chair of their Academic Training Education Standards (ATES). She serves as an Associate Editor of Behavior Therapy. She also serves on the editorial board of Cognitive Behaviour Therapy, Canadian Psychology, International Journal of Mental Health, Journal of Obsessive Compulsive and Related Disorders and the Cognitive Behavioral Therapist. She is a member of the Scientific Advisory Board of the International OCD Foundation and co-founded their Diversity Council. Her work has been featured in several major media outlets, including NPR, CBS, Huffington Post and the New York Times.


Speaker Disclosures:
Financial: Dr. Monnica Williams has employment relationships with Behavioral Wellness Clinic and the University of Ottawa. She receives royalties as a published author. Dr. Williams receives grant funding from the Marin Family Foundation, Bob and Renee Parsons Foundation, the Canada Foundation for Innovation, and the Canadian Institutes of Health Research. She receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Monnica Williams is a member of the Canadian Association for Behavioral & Cognitive Therapies, the Association for Psychological Science, and the Association for Contextual Behavioral Science. She serves on the board of directors of Psychedelic Medicines and Therapies and the Source Research Foundation. Dr. Williams serves on the editorial board of several academic journals, for a complete list contact PESI, Inc.


  1. Analyze how discrimination affects the mental health of people of colour.
  2. Theorize how race, ethnicity, and culture are important in psychedelic-assisted psychotherapy.
  3. Catalogue new research pertaining to psychedelics and racialized populations.


  • Discrimination in access to care 
  • Racism and Microaggressions 
  • The specific needs of racialized people during psychedelic-assisted psychotherapy 
  • The latest research on psychedelics and people of colour

Target Audience

  • Counsellors
  • Marriage & Family Therapists
  • Nurses
  • Nurse Practitioners
  • Physicians
  • Psychologists
  • Social Workers
  • Other Behavioral Health Professionals



Overall:      4.8

Total Reviews: 1711

Satisfaction Guarantee
Your satisfaction is our goal and our guarantee. Concerns should be addressed to or call 01235847393.

Please wait ...

Back to Top